Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Hexner

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Thescientificworldjournal|February 28, 2006
The role of T cells in hematopoietic stem cell engraftmentElizabeth Hexner
Current Opinion in Hematology|January 1, 2014
Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?Daria Babushok, Elizabeth Hexner
Molecular Diagnosis & Therapy|November 28, 2012
Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferationsGerald B W Wertheim, Elizabeth Hexner, Adam Bagg
Current Oncology Reports|September 3, 2010
Targeted signal transduction therapies in myeloid malignanciesEmma Scott, Elizabeth Hexner, Alexander Perl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host diseaseYi Zhang, Elizabeth Hexner, Dale Frank, et al.
Nature Medicine|November 17, 2005
Host-reactive CD8+ memory stem cells in graft-versus-host diseaseYi Zhang, Gerard Joe, Elizabeth Hexner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Alloreactive memory T cells are responsible for the persistence of graft-versus-host diseaseYi Zhang, Gerard Joe, Elizabeth Hexner, et al.
Expert Review of Anticancer Therapy|March 17, 2023
Pemigatinib for the treatment of myeloid/lymphoid neoplasms with <i>FGFR1</i> rearrangementCraig W Freyer, Mitchell E Hughes, Alison Carulli, et al.
Blood|February 7, 2004
Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activityYi Zhang, Gerard Joe, Jiang Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2010
Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host diseaseKoji Kato, Shuaiying Cui, Rork Kuick, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Thescientificworldjournal|February 28, 2006
The role of T cells in hematopoietic stem cell engraftmentElizabeth Hexner
Current Opinion in Hematology|January 1, 2014
Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?Daria Babushok, Elizabeth Hexner
Molecular Diagnosis & Therapy|November 28, 2012
Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferationsGerald B W Wertheim, Elizabeth Hexner, Adam Bagg
Current Oncology Reports|September 3, 2010
Targeted signal transduction therapies in myeloid malignanciesEmma Scott, Elizabeth Hexner, Alexander Perl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host diseaseYi Zhang, Elizabeth Hexner, Dale Frank, et al.
Nature Medicine|November 17, 2005
Host-reactive CD8+ memory stem cells in graft-versus-host diseaseYi Zhang, Gerard Joe, Elizabeth Hexner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Alloreactive memory T cells are responsible for the persistence of graft-versus-host diseaseYi Zhang, Gerard Joe, Elizabeth Hexner, et al.
Expert Review of Anticancer Therapy|March 17, 2023
Pemigatinib for the treatment of myeloid/lymphoid neoplasms with <i>FGFR1</i> rearrangementCraig W Freyer, Mitchell E Hughes, Alison Carulli, et al.
Blood|February 7, 2004
Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activityYi Zhang, Gerard Joe, Jiang Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2010
Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host diseaseKoji Kato, Shuaiying Cui, Rork Kuick, et al.
Pageof 6